Aptargroup (ATR) Long-Term Investments (2009 - 2026)
Aptargroup (ATR) posted quarterly Long-Term Investments of $134.8 million for Q2 2026, down 12.56% year-over-year from $154.1 million in Q2 2025, and up 3.05% on a QoQ basis from $130.8 million in Q1 2026.
Aptargroup (ATR) Long-Term Investments (2009 - 2026) Analysis & Trends
Aptargroup has reported Long-Term Investments for 18 years, with the latest figure at $134.8 million in Q2 2026.
- Long-Term Investments for Q2 2026 came in at $134.8 million, down 12.56% year-over-year; the trailing twelve-month figure through Jun 2026 was $134.8 million (down 12.56% YoY), and the FY2025 annual result was $131.0 million, down 10.42% from the prior year.
- Long-Term Investments improved to $134.8 million in Q2 2026, from $130.8 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $154.1 million in Q2 2025 and troughed at $48.0 million in Q3 2023.
- A 5-year average of $85.7 million and a median of $53.9 million in 2022 frame the typical range for Long-Term Investments.
- The widest annual swing landed in 2022, when Long-Term Investments retreated 17.43%; it then jumped 217.56% in 2025.
- A 5-year view of Long-Term Investments shows it stood at $52.3 million in 2022, then slipped by 5.94% to $49.2 million in 2023, then surged by 197.28% to $146.3 million in 2024, then decreased by 10.42% to $131.0 million in 2025, then increased by 2.84% to $134.8 million in 2026.
- Per Business Quant data, the three most recent Long-Term Investments figures were $134.8 million in Q2 2026, $130.8 million in Q1 2026, and $131.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 3.41 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 207.70 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Aptargroup | 8.58 Bn | 8.38 Bn | 365.52 Mn | 134.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 134.75 Mn |
| Mar 31, 2026 | 130.76 Mn |
| Dec 31, 2025 | 131.03 Mn |
| Sep 30, 2025 | 130.35 Mn |
| Jun 30, 2025 | 154.10 Mn |
| Mar 31, 2025 | 147.69 Mn |
| Dec 31, 2024 | 146.27 Mn |
| Sep 30, 2024 | 51.05 Mn |
| Jun 30, 2024 | 48.53 Mn |
| Mar 31, 2024 | 48.91 Mn |
| Dec 31, 2023 | 49.20 Mn |
| Sep 30, 2023 | 48.02 Mn |
| Jun 30, 2023 | 53.88 Mn |
| Mar 31, 2023 | 52.58 Mn |
| Dec 31, 2022 | 52.31 Mn |
| Sep 30, 2022 | 51.49 Mn |
| Jun 30, 2022 | 53.84 Mn |
| Mar 31, 2022 | 57.14 Mn |
| Dec 31, 2021 | 59.49 Mn |
| Sep 30, 2021 | 62.34 Mn |